BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 24821431)

  • 41. Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians.
    Abbott WG; Swinburn B; Ruotolo G; Hara H; Patti L; Harper I; Grundy SM; Howard BV
    J Clin Invest; 1990 Aug; 86(2):642-50. PubMed ID: 2200808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies.
    Watts GF; Chan DC; Ooi EM; Nestel PJ; Beilin LJ; Barrett PH
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):877-82. PubMed ID: 16922825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations.
    Ooi EM; Russell BS; Olson E; Sun SZ; Diffenderfer MR; Lichtenstein AH; Keilson L; Barrett PH; Schaefer EJ; Sprecher DL
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):459-66. PubMed ID: 22095987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome.
    Richard C; Couture P; Ooi EM; Tremblay AJ; Desroches S; Charest A; Lichtenstein AH; Lamarche B
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):433-8. PubMed ID: 24265415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men.
    Dash S; Xiao C; Morgantini C; Szeto L; Lewis GF
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2895-901. PubMed ID: 24072699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men.
    Wong AT; Chan DC; Ooi EM; Ng TW; Watts GF; Barrett PH
    Clin Sci (Lond); 2013 Mar; 125(1):45-51. PubMed ID: 23356247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.
    Fabbrini E; Mohammed BS; Magkos F; Korenblat KM; Patterson BW; Klein S
    Gastroenterology; 2008 Feb; 134(2):424-31. PubMed ID: 18242210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects.
    Magkos F; Fabbrini E; Patterson BW; Eagon JC; Klein S
    Metabolism; 2011 Nov; 60(11):1641-8. PubMed ID: 21632078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
    Qin B; Anderson RA; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
    dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
    Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interrelationships between the kinetics of VLDL subspecies and HDL catabolism in abdominal obesity: a multicenter tracer kinetic study.
    Vergès B; Adiels M; Boren J; Barrett PH; Watts GF; Chan D; Duvillard L; Söderlund S; Matikainen N; Kahri J; Robin I; Taskinen MR
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4281-90. PubMed ID: 25077901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.
    Fabbrini E; Mohammed BS; Korenblat KM; Magkos F; McCrea J; Patterson BW; Klein S
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2727-35. PubMed ID: 20371660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
    Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
    Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determinants of the kinetics of very low-density lipoprotein apolipoprotein B-100 in non-obese men.
    Watts GF; Riches FM; Kelly JM; Powell MA; Croft KD
    Clin Exp Pharmacol Physiol; 1997 Aug; 24(8):556-62. PubMed ID: 9269527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VLDL Triglyceride Kinetics in Lean, Overweight, and Obese Men and Women.
    Mittendorfer B; Yoshino M; Patterson BW; Klein S
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4151-4160. PubMed ID: 27588438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subclinical hypothyroidism and hyperthyroidism have opposite effects on hepatic very-low-density lipoprotein-triglyceride kinetics.
    Fabbrini E; Magkos F; Patterson BW; Mittendorfer B; Klein S
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E414-8. PubMed ID: 22238397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skeletal muscle apolipoprotein B expression reduces muscular triglyceride accumulation.
    Bartels ED; Ploug T; Størling J; Mandrup-Poulsen T; Nielsen LB
    Scand J Clin Lab Invest; 2014 Jun; 74(4):351-7. PubMed ID: 24673444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
    Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Kelly JM; Jackson NC; Sönksen PH
    Diabetes; 1995 Sep; 44(9):1059-65. PubMed ID: 7657029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ATP-binding cassette transporter G8 gene as a determinant of apolipoprotein B-100 kinetics in overweight men.
    Chan DC; Watts GF; Barrett PH; Whitfield AJ; van Bockxmeer FM
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2188-91. PubMed ID: 15331430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction.
    Magkos F; Fabbrini E; Mohammed BS; Patterson BW; Klein S
    Obesity (Silver Spring); 2010 Aug; 18(8):1510-5. PubMed ID: 20395947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.